Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 11 of 27
 |<   <<   <  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  >   >>   >| 

Scientific Advancements
Tuesday, June 14, 2022   (0 Comments - view/add)
Oragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candi »
Oragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Re...
Tuesday, June 14, 2022   (0 Comments - view/add)
Jupiter Neurosciences, Inc. Announces Journal of Alzheimer's Disease Publication Highlighting use of »
Jupiter Neurosciences, Inc. Announces Journal of Alzheimer's Disease Publication Highlighting use of JOTROL™ Pre-clin...
Monday, June 13, 2022   (0 Comments - view/add)
LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System »
LENSAR ® Receives U.S. FDA Clearance of ALLY ™ Adaptive Cataract Treatment System...
Friday, June 10, 2022   (0 Comments - view/add)
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibod »
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress...
Tuesday, June 7, 2022   (0 Comments - view/add)
Veru Submits Emergency Use Authorization (EUA) Application to U.S. FDA for Sabizabulin, its Novel, O »
Veru Submits Emergency Use Authorization (EUA) Application to U.S. FDA for Sabizabulin, its Novel, Oral Antiviral and...
Thursday, June 2, 2022   (0 Comments - view/add)
Rapid Medical Enrolls the First Patient in the DISTALS Stroke Trial–Offering Treatment to New Ischem »
Rapid Medical Enrolls the First Patient in the DISTALS Stroke Trial–Offering Treatment to New Ischemic Stroke Patient Popu...
Wednesday, June 1, 2022   (0 Comments - view/add)
KemPharm Announces Research Affirming Serdexmethylphenidate’s Lower Potential for Abuse Featured in »
KemPharm Announces Research Affirming Serdexmethylphenidate’s Lower Potential for Abuse Featured in Peer-Reviewed Publicat...
Monday, May 23, 2022   (0 Comments - view/add)
Xcovery SHP2 Inhibitor IND Approved by US FDA »
Xcovery SHP2 Inhibitor IND Approved by US FDA...
Friday, May 20, 2022   (0 Comments - view/add)
TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug A »
TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) fo...
Tuesday, May 17, 2022   (0 Comments - view/add)
Exactech Announces FDA Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing »
Exactech Announces FDA Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System...
Monday, May 16, 2022   (0 Comments - view/add)
iTolerance, Inc. Pre-Clinical Non-Human Primate Study Demonstrates Long-Term Success of Allogeneic »
iTolerance, Inc. Pre-Clinical Non-Human Primate Study Demonstrates Long-Term Success of Allogeneic Islet Implantation...
Monday, May 16, 2022   (0 Comments - view/add)
AGTC Announces Positive Three-Month Interim Results from Skyline Trial of AGTC-501 for the Treatment »
AGTC Announces Positive Three-Month Interim Results from Skyline Trial of AGTC-501 for the Treatment of X-Linked Retin...
Tuesday, May 10, 2022   (0 Comments - view/add)
New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both Planktonic Bacter »
New Study Finds XPERIENCE ™ No Rinse Solution Has Persistent Efficacy Against Both Planktonic Bacteria and Bacterial Biof...
Tuesday, May 10, 2022   (0 Comments - view/add)
FIU researcher part of team that has developed new miniature heart »
FIU researcher part of team that has developed new miniature heart The miniPUMP mimics the real organ and could help...
Thursday, May 5, 2022   (0 Comments - view/add)
KemPharm Announces Submission of Investigational New Drug Application for Phase 2 Trial of KP1077 in »
KemPharm Announces Submission of Investigational New Drug Application for Phase 2 Trial of KP1077 in Idiopathic Hypersomni...
Wednesday, May 4, 2022   (0 Comments - view/add)
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Associatio »
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in...
Monday, May 2, 2022   (0 Comments - view/add)
AGTC to Present Preclinical Research Supporting Gene Therapy Platform in Frontotemporal Dementia at »
AGTC to Present Preclinical Research Supporting Gene Therapy Platform in Frontotemporal Dementia at the 25th Annual Me...
Monday, May 2, 2022   (0 Comments - view/add)
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin P »
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study...
Saturday, April 23, 2022   (0 Comments - view/add)
Orasis Pharmaceuticals Announces Phase 2b Trial Efficacy and Safety Results of Novel Presbyopia Eye »
Orasis Pharmaceuticals Announces Phase 2b Trial Efficacy and Safety Results of Novel Presbyopia Eye Drop Candidate, CSF-...
Thursday, April 21, 2022   (0 Comments - view/add)
AIM ImmunoTech Provides Summary of Ampligen® Data Supporting Synergistic Potential with Checkpoint B »
AIM ImmunoTech Provides Summary of Ampligen® Data Supporting Synergistic Potential with Checkpoint Blockade Therapies...
Tuesday, April 19, 2022   (0 Comments - view/add)
Hesperos Shows Potential for In Vitro Approach to Replace Conventional Animal Efficacy Studies for R »
Hesperos Shows Potential for In Vitro Approach to Replace Conventional Animal Efficacy Studies for Rare Neuromuscular Diso...
Tuesday, April 19, 2022   (0 Comments - view/add)
KemPharm Doses First Subject in Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmet »
KemPharm Doses First Subject in Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate (SDX)...
Thursday, April 14, 2022   (0 Comments - view/add)
Akron BioProducts Announces Launch of its Closed System Solutions™ line to Enable Seamless Integrati »
Akron BioProducts Announces Launch of its Closed System Solutions™ line to Enable Seamless Integration of cGMP Ancilla...
Thursday, April 14, 2022   (0 Comments - view/add)
Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples »
Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples Test provides...
Thursday, April 14, 2022   (0 Comments - view/add)
New Study Shows No Revisions and a Low Complication Rate for Exactech’s Vantage® Total Ankle Fixed B »
New Study Shows No Revisions and a Low Complication Rate for Exactech’s Vantage® Total Ankle Fixed Bearing System...
Tuesday, April 12, 2022   (0 Comments - view/add)
AIM ImmunoTech Provides Progress on Advancement of Ampligen® Clinical Development Program for the Tr »
AIM ImmunoTech Provides Progress on Advancement of Ampligen® Clinical Development Program for the Treatment of Pancreatic...
Monday, April 11, 2022   (0 Comments - view/add)
Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analy »
Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Stu...
Tuesday, April 5, 2022   (0 Comments - view/add)
Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic F »
Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic Foot Ulcers (cDFU)...
Friday, April 1, 2022   (0 Comments - view/add)
Merck and Ridgeback to Present Data Demonstrating That Treatment With LAGEVRIO™ (molnupiravir) Was »
Merck and Ridgeback to Present Data Demonstrating That Treatment With LAGEVRIO™ (molnupiravir) Was Associated With More...
Thursday, March 31, 2022   (0 Comments - view/add)
Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disea »
Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s...
Monday, March 21, 2022   (0 Comments - view/add)
KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial »
KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial March 21...
Thursday, March 17, 2022   (0 Comments - view/add)
Thursday, March 10, 2022   (0 Comments - view/add)
S.M.A.R.T. RADIANZ™ Vascular Stent System Approved for Transradial Use in the U.S. »
S.M.A.R.T. RADIANZ™ Vascular Stent System Approved for Transradial Use in the U.S. Completes the RADIANZ Radial Periphe...
Wednesday, March 9, 2022   (0 Comments - view/add)
INSIGHTEC Receives FDA IDE Approval and "Breakthrough" Designation for NSCLC Brain Mets Study and ID »
INSIGHTEC RECEIVES FDA IDE APPROVAL AND "BREAKTHROUGH" DESIGNATION FOR NSCLC BRAIN METS STUDY AND IDE APPROVAL FOR LIQUI...
Tuesday, March 8, 2022   (0 Comments - view/add)
AIM ImmunoTech Announces Publication of Positive Data from Late-Stage Pancreatic Cancer Early Access »
AIM ImmunoTech Announces Publication of Positive Data from Late-Stage Pancreatic Cancer Early Access Program (EAP) in...

Displaying page 11 of 27
 |<   <<   <  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  >   >>   >| 

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)